Hope for cancer sufferers in Spain as breakthrough ‘personalised’ mRNA vaccine keeps pancreatic cancer patients alive six years later
A CLINICAL trial using personalised messenger mRNA vaccines to treat pancreatic cancer has had some promising results. Less than 13% of people diagnosed with pancreatic